Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone

article OA: closed CC0 ⤵ 14 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Danazol Dexamethasone Endometriosis Estradiol Pelvic Neoplasms Pregnadienes Spironolactone Adult Age Factors Body Weight Danazol Danazol Dexamethasone Dexamethasone Drug Administration Schedule Drug Therapy, Combination Endometriosis Endometriosis Estradiol Female

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (25)

Cited by (14)

SciLite annotations

chemicals 9
estradiol danazol spironolactone dexamethasone estradiol danazol dexamethasone spironolactone androgen

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:09:50.790931+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK